Systems genetic dissection of Alzheimer's disease brain gene expression networks

Pinghan Zhao,Omar El Fadel,Anh Le,Carl Grant Mangleburg,Justin Dhindsa,Timothy Wu,Jinghan Zhao,Meichen Huang,Bismark Amoh,Aditi Sai Marella,Yarong Li,Nicholas T Seyfried,Allan I Levey,Zhandong Liu,Ismael Al Ramahi,Juan Botas,Joshua M Shulman

DOI: https://doi.org/10.1101/2024.10.04.616661

2024-10-04

Abstract:In Alzheimer's disease (AD), changes in the brain transcriptome are hypothesized to mediate the impact of neuropathology on cognition. Gene expression profiling from postmortem brain tissue is a promising approach to identify causal pathways; however, there are challenges to definitively resolve the upstream pathologic triggers along with the downstream consequences for AD clinical manifestations. We have functionally dissected 30 AD-associated gene coexpression modules using a cross-species strategy in fruit fly (Drosophila melanogaster) models. Integrating longitudinal RNA-sequencing and behavioral phenotyping, we interrogated the unique and shared transcriptional responses to amyloid beta (Aβ) plaques, tau neurofibrillary tangles, and/or aging, along with potential links to progressive neuronal dysfunction. Our results highlight hundreds of conserved, differentially expressed genes mapping to human AD regulatory networks. To confirm causal modules and pinpoint AD network drivers, we performed systematic in vivo genetic manipulations of 357 conserved, prioritized targets, identifying 141 modifiers of Aβ- and/or tau-induced neurodegeneration. We discover an up-regulated network that is significantly enriched for both AD risk variants and markers of immunity / inflammation, and which promotes Aβ and tau-mediated neurodegeneration based on fly genetic manipulations in neurons. By contrast, a synaptic regulatory network is strongly downregulated in human brains with AD and is enriched for loss-of-function suppressors of Aβ/tau in Drosophila. Additional experiments suggest that this human brain transcriptional module may respond to and modulate Aβ-induced glutamatergic hyperactivation injury. In sum, our cross-species, systems genetic approach establishes a putative causal chain linking AD pathology, large-scale gene expression perturbations, and ultimately, neurodegeneration.

Systems Biology

What problem does this paper attempt to address?

This paper attempts to address the question of how transcriptional changes in the brain in Alzheimer's disease (AD) mediate the impact of neuropathology on cognition. Specifically, the study aims to identify causal pathways by analyzing gene expression profiles in post - mortem brain tissue while addressing several major challenges:

1. **Clear separation of upstream pathological triggers and downstream clinical manifestations**: Determine the specific upstream pathological triggers that lead to AD clinical symptoms and how these factors initiate downstream gene expression changes.
2. **Simulation of dynamic processes**: The pathophysiological process of AD is a dynamic process that lasts for decades, while the human brain transcriptome can only be detected at one time point after death. Therefore, it is necessary to simulate this dynamic process to better understand the progression of the disease.
3. **Confirmation of causal gene expression changes**: Identify gene expression changes that can alter the onset, progression, or neurodegeneration of AD, and distinguish whether these changes promote the disease or act as a compensatory mechanism.
4. **Analysis of modular structures**: Transcriptional changes are composed of co - expression networks consisting of hundreds or thousands of genes. It is necessary to analyze the fine - structure of these networks to identify key driver genes, which may have the potential to restore regulatory homeostasis.

To address these challenges, the researchers adopted a cross - species approach and used the Drosophila melanogaster model for functional dissection. By integrating longitudinal RNA sequencing and behavioral phenotyping, the researchers explored the unique and shared transcriptional responses induced by amyloid - beta (Aβ) plaques, tau neurofibrillary tangles, and/or aging, as well as their potential links to progressive neuronal dysfunction.

The main findings of the study include:
- Identification of hundreds of conserved differentially expressed genes that map to the human AD regulatory network.
- By systematically genetically manipulating 357 conserved target genes in vivo, 141 genes that modify Aβ - and/or tau - induced neurodegeneration were identified.
- Discovery of an up - regulated network significantly enriched in AD risk variants and immune/inflammatory markers, which, based on the results of Drosophila genetic manipulation in neurons, promotes Aβ - and tau - mediated neurodegeneration.
- Identification of a synaptic regulatory network that is strongly down - regulated in the human AD brain and is rich in Aβ/tau inactivation inhibitors in Drosophila.
- Further experiments indicate that this human brain transcriptional module may respond to and regulate Aβ - induced glutamatergic hyperactivation damage.

In summary, this cross - species systems genetics approach has established a hypothesized causal chain linking AD pathology, large - scale gene expression perturbations, and ultimately neurodegeneration.